Myeloproliferative Disorders clinical trials at UCSF
1 research study open to eligible people
Myeloproliferative disorders are conditions where the body makes too many blood cells. UCSF is using AI technology to better match cancer patients to clinical trials. The study looks into how AI can improve the way we connect patients with the right studies for their condition.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
open to all eligible people
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical trial enrollment (CTE), as well as the financial impact, and potential outcomes of the intervention.
San Francisco, California and other locations
Last updated: